Karen L Tubridy Insider Trading $SESN Sesen Bio, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Karen L Tubridy.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Karen L Tubridy. Karen L Tubridy is Chief Development Officer in Eleven Biotherapeutics, Inc. ($EBIO) and SVP, Chief Development Officer in Akebia Therapeutics, Inc. ($AKBA).
Karen L Tubridy in Sesen Bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Karen L Tubridy: Chief Development Officer
Holdings: 32,753 shares
Current Value: $76,642
Latest Transaction: Jul 12 2016
$SESN Market Capitalization: $34.48M
$SESN Previous Close: $2.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Karen L Tubridy in Sesen Bio, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 12 2016 | EBIO | Eleven Biotherapeu ... | Tubridy Karen L | Chief Development O ... | Option Exercise | A | 0.28 | 13,328 | 3,732 | 26,672 | |
| Jul 12 2016 | EBIO | Eleven Biotherapeu ... | Tubridy Karen L | Chief Development O ... | Option Exercise | A | 0.28 | 13,328 | 3,732 | 26,672 | |
| Jun 29 2016 | EBIO | Eleven Biotherapeu ... | Tubridy Karen L | Chief Development O ... | Sell | S | 2.08 | 4,372 | 9,094 | 32,753 | 37.1 K to 32.8 K (-11.78 %) |
| Jun 17 2016 | EBIO | Eleven Biotherapeu ... | Tubridy Karen L | Chief Development O ... | Option Exercise | A | 0.28 | 13,344 | 3,736 | 13,344 | |
| Feb 29 2016 | EBIO | Eleven Biotherapeu ... | Tubridy Karen L | Chief Development O ... | Option Exercise | A | 0.28 | 40,000 | 11,200 | 40,000 | |
| Feb 29 2016 | EBIO | Eleven Biotherapeu ... | Tubridy Karen L | Chief Development O ... | Option Exercise | A | 0.28 | 60,400 | 16,912 | 60,400 | |
| Dec 30 2015 | EBIO | Eleven Biotherapeu ... | Tubridy Karen L | Chief Development O ... | Sell | S | 2.85 | 4,427 | 12,617 | 32,973 | 37.4 K to 33 K (-11.84 %) |
| Jun 29 2015 | EBIO | Eleven Biotherapeu ... | Tubridy Karen L | Chief Development O ... | Grant | A | 0.00 | 37,400 | 0 | 37,400 | 0 to 37.4 K |
| Feb 27 2015 | EBIO | Eleven Biotherapeu ... | Tubridy Karen L | Chief Development O ... | Option Exercise | A | 10.39 | 65,000 | 675,350 | 150,827 |
Page: 1